798 related articles for article (PubMed ID: 27386968)
1. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
2. Biological therapies in the treatment of cutaneous lupus erythematosus.
Presto JK; Hejazi EZ; Werth VP
Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of cutaneous lupus erythema associated with and without systemic lupus erythema.
Zhang YP; Wu J; Han YF; Shi ZR; Wang L
Autoimmun Rev; 2017 Jul; 16(7):735-742. PubMed ID: 28483542
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous and systemic connections in lupus.
Maz MP; Michelle Kahlenberg J
Curr Opin Rheumatol; 2020 Nov; 32(6):583-589. PubMed ID: 32826479
[TBL] [Abstract][Full Text] [Related]
5. Update on pathogenesis and treatment of CLE.
Privette ED; Werth VP
Curr Opin Rheumatol; 2013 Sep; 25(5):584-90. PubMed ID: 23872903
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
Stannard JN; Kahlenberg JM
Curr Opin Rheumatol; 2016 Sep; 28(5):453-9. PubMed ID: 27270345
[TBL] [Abstract][Full Text] [Related]
7. An Update on the Pathogenesis of Skin Damage in Lupus.
Li Q; Wu H; Zhou S; Zhao M; Lu Q
Curr Rheumatol Rep; 2020 May; 22(5):16. PubMed ID: 32399815
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
Lee HJ; Sinha AA
Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
[TBL] [Abstract][Full Text] [Related]
9. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DW; Gordon R; Hsu B
Arthritis Rheum; 2013 Oct; 65(10):2661-71. PubMed ID: 23896980
[TBL] [Abstract][Full Text] [Related]
10. Immunogenetics of Lupus Erythematosus.
Ünlü B; Türsen Ü; Jabalameli N; Abdollahimajd F; Rajabi F
Adv Exp Med Biol; 2022; 1367():213-257. PubMed ID: 35286698
[TBL] [Abstract][Full Text] [Related]
11. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
Yu C; Chang C; Zhang J
J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.
Foulke G; Helm LA; Clebak KT; Helm M
FP Essent; 2023 Mar; 526():25-36. PubMed ID: 36913660
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic approach and treatment of cutaneous lupus erythematosus.
Sticherling M; Bonsmann G; Kuhn A
J Dtsch Dermatol Ges; 2008 Jan; 6(1):48-59. PubMed ID: 18190433
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
Mikita N; Ikeda T; Ishiguro M; Furukawa F
J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
[TBL] [Abstract][Full Text] [Related]
15. Immunogenetics of systemic lupus erythematosus: A comprehensive review.
Ghodke-Puranik Y; Niewold TB
J Autoimmun; 2015 Nov; 64():125-36. PubMed ID: 26324017
[TBL] [Abstract][Full Text] [Related]
16. Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus.
Chen KL; Krain RL; Werth VP
F1000Res; 2019; 8():. PubMed ID: 30984372
[TBL] [Abstract][Full Text] [Related]
17. Novel biological therapeutic approaches to cutaneous lupus erythematosus.
Tayer-Shifman OE; Rosen CF; Wakani L; Touma Z
Expert Opin Biol Ther; 2018 Oct; 18(10):1041-1047. PubMed ID: 30118337
[TBL] [Abstract][Full Text] [Related]
18. Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
Lim D; Kleitsch J; Werth VP
Expert Opin Emerg Drugs; 2023 Dec; 28(4):257-273. PubMed ID: 37860982
[TBL] [Abstract][Full Text] [Related]
19. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
Cho YM; Furie R
Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Niebel D; de Vos L; Fetter T; Brägelmann C; Wenzel J
Am J Clin Dermatol; 2023 Jul; 24(4):521-540. PubMed ID: 37140884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
